Sign in

CIK 0001159036

  • Large accelerated filer

HALOZYME THERAPEUTICS, INC.

Sign in to watch
Ticker
HALO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880488686
Phone
+1 858-794-8889
Business address
12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
Former names
HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
  1. 4 Grant or award Director acquired 8,065 shares (grant or award)
  2. 4 Grant or award Director acquired 8,065 shares (grant or award)
  3. 4 Grant or award Director acquired 8,065 shares (grant or award)
  4. 4 Planned sale SVP, CHIEF TECHNICAL OFFICER sold 10,000 shares at $36.00 ($360,000)
  5. 4/A Planned sale SVP, CHIEF TECHNICAL OFFICER sold 2,984 shares at $49.55 ($147,854)
  6. 4 Open-market sale PRESIDENT AND CEO sold 30,000 shares at an average $43.82 ($1,314,550)
  7. 4 Gift PRESIDENT AND CEO gave 10,000 shares (gift)
  8. 4 Open-market sale Director sold 20,000 shares at an average $48.11 ($962,200)
  9. 4 Open-market sale SVP, CHIEF TECHNICAL OFFICER sold 10,000 shares at an average $49.55 ($495,483)
  10. 4 Open-market sale SVP, CHIEF TECHNICAL OFFICER sold 2,878 shares at $49.26 ($141,770)
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market sale SVP, CHIEF FINANCIAL OFFICER sold 2,525 shares at $49.26 ($124,382)
  13. 4 Open-market sale PRESIDENT AND CEO sold 11,061 shares at $49.26 ($544,865)
  14. 4 Open-market sale SVP, CHIEF TECHNICAL OFFICER sold 10,000 shares at $48.39 ($483,940)
  15. 4 Shares withheld for taxes SVP, CHIEF FINANCIAL OFFICER gave up 621 shares (to pay taxes)
  16. 4 Shares withheld for taxes PRESIDENT AND CEO gave up 6,892 shares (to pay taxes)
  17. 4 Shares withheld for taxes SVP, CHIEF TECHNICAL OFFICER gave up 5,676 shares (to pay taxes)
  18. 4 Shares withheld for taxes SVP, CHIEF FINANCIAL OFFICER gave up 2,073 shares (to pay taxes)
  19. 4 Shares withheld for taxes PRESIDENT AND CEO gave up 33,735 shares (to pay taxes)
  20. 4 Open-market sale PRESIDENT AND CEO sold 30,000 shares at an average $51.01 ($1,530,150)

Page 9 of 39 · 774 filings